Regni Catherine, Tipton Peter A, Beamer Lesa J
Department of Biochemistry, 117 Schweitzer Hall, University of Missouri-Columbia, Columbia, MO 65211, USA.
Structure. 2002 Feb;10(2):269-79. doi: 10.1016/s0969-2126(02)00705-0.
The enzyme phosphomannomutase/phosphoglucomutase (PMM/PGM) from P. aeruginosa is required for the biosynthesis of two bacterial exopolysaccharides: alginate and lipopolysaccharide (LPS). Both of these molecules play a role in the virulence of P. aeruginosa, an important human pathogen known for its ability to develop antibiotic resistance and cause chronic lung infections in cystic fibrosis patients. The crystal structure of PMM/PGM shows that the enzyme has four domains, three of which have a similar three-dimensional fold. Residues from all four domains of the protein contribute to the formation of a large active site cleft in the center of the molecule. Detailed information on the active site of PMM/PGM lays the foundation for structure-based inhibitor design. Inhibitors of sufficient potency and specificity should impair the biosynthesis of alginate and LPS, and may facilitate clearance of the bacteria by the host immune system and increase the efficacy of conventional antibiotic treatment against chronic P. aeruginosa infections.
铜绿假单胞菌中的磷酸甘露糖变位酶/磷酸葡萄糖变位酶(PMM/PGM)是两种细菌胞外多糖(藻酸盐和脂多糖,LPS)生物合成所必需的。这两种分子在铜绿假单胞菌的毒力中都发挥作用,铜绿假单胞菌是一种重要的人类病原体,以其产生抗生素耐药性和在囊性纤维化患者中引起慢性肺部感染的能力而闻名。PMM/PGM的晶体结构表明,该酶有四个结构域,其中三个具有相似的三维折叠。蛋白质所有四个结构域的残基都有助于在分子中心形成一个大的活性位点裂缝。关于PMM/PGM活性位点的详细信息为基于结构的抑制剂设计奠定了基础。具有足够效力和特异性的抑制剂应会损害藻酸盐和LPS的生物合成,并可能促进宿主免疫系统清除细菌,并提高传统抗生素治疗慢性铜绿假单胞菌感染的疗效。